Unique Ingredient Identifier 2G86QN327L is listed as a unspecified ingredient
| RN | 9000-70-8 |
| EC | 232-554-6 |
| NCIT | C65802 |
| RXCUI | 4716 |
UNII 2G86QN327L GELATIN, UNSPECIFIED is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | CAPSULE | 136.5 mg |
| ORAL | CAPSULE, DELAYED RELEASE | 63.46 mg |
| ORAL | CAPSULE, EXTENDED RELEASE | 117.2 mg |
| ORAL | CAPSULE, SOFT GELATIN | 95.73 mg |
| ORAL | TABLET | 12 mg |
| BUCCAL | GUM, CHEWING | 4.27 MG |
| DENTAL | PASTE | 180 MG |
| IM - IV - SC | INJECTION | 16 % |
| IM - IV - SC | POWDER, FOR INJECTION SOLUTION | 1.4 % |
| IM - SC | INJECTION | 16 % |
| IM - SC | INJECTION, SUSTAINED ACTION | 16 % |
| INHALATION | POWDER | 100 MG |
| INTRA-ARTICULAR | SUSPENSION | 0.03 % |
| INTRAMUSCULAR | INJECTION | 0.26 % |
| INTRAMUSCULAR | INJECTION, MICROSPHERES | 0.13 % |
| INTRAMUSCULAR | SUSPENSION | 0.03 % |
| INTRAVENOUS | SOLUTION | 3.48 % |
| IV(INFUSION) | INJECTION | 2 % |
| ORAL | BAR, CHEWABLE | NA |
| ORAL | CAPSULE | 657 MG |
| ORAL | CAPSULE | QS |
| ORAL | CAPSULE (IMMED./COMP. RELEASE) | 50.86 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELAT | 88.97 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN | 94.87 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN | 260.85 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERL | 95.21 MG |
| ORAL | CAPSULE, COATED PELLETS | 65 MG |
| ORAL | CAPSULE, COATED, SOFT GELATIN | 153.7 MG |
| ORAL | CAPSULE, DELAYED ACTION | 116.23 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, DELAYED RELEASE | 78.64 MG |
| ORAL | CAPSULE, DELAYED RELEASE | QS |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 84.6 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 122.87 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | QS |
| ORAL | CAPSULE, FILM COATED, EXTENDED RELEASE | 93.4765 MG |
| ORAL | CAPSULE, HARD GELATIN | 52.75 MG |
| ORAL | CAPSULE, SOFT GELATIN | 733 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 194 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 217.86 MG |
| ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 107 MG |
| ORAL | DROPS | NA |
| ORAL | PASTILLE | 143 MG |
| ORAL | POWDER, FOR SUSPENSION | NA |
| ORAL | SOFT CAPSULE DOSAGE FORM | 129.639 mg |
| ORAL | SOLUTION | 34.8 MG |
| ORAL | SOLUTION, ELIXIR | NA |
| ORAL | SYRUP | NA |
| ORAL | TABLET | 7.8 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 2 MG |
| ORAL | TABLET, COATED | 42.12 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 15 MG |
| ORAL | TABLET, DELAYED RELEASE | NA |
| ORAL | TABLET, FILM COATED | 28.35 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 23.75 MG |
| ORAL | TABLET, REPEAT ACTION | 1.61 MG |
| ORAL | TABLET, SUSTAINED ACTION | 40 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | NA |
| ORAL | WAFER | NA |
| RESPIRATORY (INHALATION) | POWDER, FOR INHALATION | 10 % |
| SUBLINGUAL | TABLET | 10 MG |
| SUBLINGUAL | TABLET, ORALLY DISINTEGRATING | 12.5 mg |
| TOPICAL | EMULSION, CREAM | NA |
| TOPICAL | FILM, CONTROLLED RELEASE | NA |
| TOPICAL | PASTE | NA |
| TOPICAL | PASTE, DENTIFRICE | NA |
| TOPICAL | PATCH | 210 MG |
| TOPICAL | PATCH, CONTROLLED RELEASE | NA |
| TOPICAL | SUPPOSITORY, INSERT | NA |
| VAGINAL | INSERT | 150.5 MG |
| VAGINAL | SUPPOSITORY | NA |